Financial Contrast: HeartBeam (NASDAQ:BEAT) & CVR Medical (OTCMKTS:CRRVF)

HeartBeam (NASDAQ:BEAT) and CVR Medical (OTCMKTS:CRRVF) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, risk, valuation, dividends, earnings and analyst recommendations.

Institutional & Insider Ownership

7.8% of HeartBeam shares are owned by institutional investors. 18.0% of HeartBeam shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Earnings & Valuation

This table compares HeartBeam and CVR Medical”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HeartBeam	N/A	N/A	-$21.01 million	($0.56)	-1.64
CVR Medical	N/A	N/A	N/A	($0.02)	N/A

HeartBeam is trading at a lower price-to-earnings ratio than CVR Medical, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current recommendations and price targets for HeartBeam and CVR Medical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HeartBeam	1	2	4	1	2.63
CVR Medical	0	0	0	0	0.00

HeartBeam presently has a consensus price target of $4.83, indicating a potential upside of 427.66%. Given HeartBeam’s stronger consensus rating and higher probable upside, equities research analysts clearly believe HeartBeam is more favorable than CVR Medical.

Profitability

This table compares HeartBeam and CVR Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
HeartBeam	N/A	-1,034.04%	-434.40%
CVR Medical	N/A	N/A	N/A

Volatility & Risk

HeartBeam has a beta of -0.86, indicating that its stock price is 186% less volatile than the S&P 500. Comparatively, CVR Medical has a beta of 32.6, indicating that its stock price is 3,160% more volatile than the S&P 500.

Summary

HeartBeam beats CVR Medical on 6 of the 10 factors compared between the two stocks.

About HeartBeam

BioTelemetry, Inc., a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. It operates in two segments, Healthcare and Research. The Healthcare segment focuses on the remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry services; and event monitoring services, which enable physicians to prescribe wireless event, digital loop event, memory loop event, memory loop event, and non-loop event monitors. It also provides traditional and extended Holter, pacemaker, international normalized ratio, implantable loop recorder, and other implantable cardiac device monitoring services. It serves cardiologists, electrophysiologists, neurologists, and primary care physicians. The Research segment offers laboratory services, such as cardiac monitoring, imaging, scientific consulting, and data management services for drug and medical device trials. Its centralized services comprise electrocardiogram, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, expert reporting, and statistical analysis. It also provides support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The company also focuses on manufacturing, testing, and marketing of cardiac devices and blood glucose monitoring devices, as well as offers contract manufacturing services. BioTelemetry, Inc. was founded in 1994 and is headquartered in Malvern, Pennsylvania.

About CVR Medical

CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.